The US FDA has approved AstraZeneca’s drug for the treatment of solid tumours

The US Food and Drug Administration has granted accelerated approval for the expanded use of Daiichi Sankyo and AstraZeneca’s drug to treat patients with solid tumours.

Share This Post: